Aptamer Group PLC (AIM:APTA)

Market Cap	22.25M
Revenue (ttm)	1.20M
Net Income (ttm)	-2.42M
Shares Out	2.70B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,083,442
Average Volume	9,814,034
Open	0.8525
Previous Close	0.8500
Day's Range	0.8000 - 0.9000
52-Week Range	0.2100 - 1.5700
Beta	0.72
RSI	44.12
Earnings Date	Mar 11, 2026

About Aptamer Group

Aptamer Group PLC, together with its subsidiaries, provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers; and Optimer +, a platform that discovers and develops of hybrid DNA-protein molecules that combines the features of Optimer and antibodies. It serves bioprocessing and diagnostic institutes, as well as pharmaceutical scientists. The company h...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 31
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: APTA

Financial Performance

In 2025, Aptamer Group's revenue was 1.20 million, an increase of 39.88% compared to the previous year's 860,000. Losses were -2.42 million, -18.05% less than in 2024.